Gabriella Camboni

CEO Biovelocita

Gabriella is a co-Founder of Enthera and previously acted as CEO. Gabriella is member of Enthera Board of Directors since 2016, and also holds Board positions at Mission Therapeutics and Genenta.

Previously, Gabriella co-founded and acted as COO of EOS (Ethical Oncology Science) until the acquisition of the company by Clovis Oncology in 2013. Prior to this, Gabriella held various managerial positions in the biotech and pharma industry. She co-founded and acted as Head of Development at Novuspharma, and as Head of Medical Affairs Europe in Novartis Oncology.

Gabriella holds a degree in Medicine from the University of Milan, specializing in Gastroenterology and Clinical Pharmacology.